Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
June 14, 2021 Cover
Volume 99, Issue 22
Major steelmakers and disruptive start-ups look to hydrogen and renewable electricity to make green steel
Cover image:Major steelmakers and disruptive start-ups look to hydrogen and renewable electricity to decarbonize production
Credit: Shutterstock
Volume 99 |
Issue 22
Will the biodegradable plastic PHA finally deliver?
Producers of the polymer say they are getting traction in the marketplace, but others have doubts
Beirut-based atmospheric chemist Najat Saliba discusses the challenges of doing science during political and economic turmoil
The atmospheric chemist is studying the Beirut chemical explosion’s effects on air pollution
-
Defining your career wins
Achieving goals is more fulfilling when you set the terms of success
-
Scientists torn over Biogen’s new Alzheimer’s drug
The FDA approved Aduhelm based on its ability to lower amyloid-β plaques in the brain. Many researchers think it was the wrong decision.
-
Kojin Therapeutics gets $60 million to explore ferroptosis
The biotech firm aims to take advantage of cellular plasticity
ADVERTISEMENT
Science Concentrates
- Directed evolution suggests way viruses could have evolved
- The global mass of SARS-CoV-2
- Nikole Hannah-Jones tenure dispute causes a chemist to withdraw from UNC faculty search
- Reduction carves path to chiral compounds
- Spontaneously arising electric fields affect reactions on catalyst particles in solution
Scientists torn over Biogen’s new Alzheimer’s drug
The FDA approved Aduhelm based on its ability to lower amyloid-β plaques in the brain. Many researchers think it was the wrong decision.
Business & Policy Concentrates
- Massive blue hydrogen investment planned in North America
- Cargill and Helm form joint venture to build $300 million biobased 1,4-butanediol plant in Iowa
- White House tackles persistent supply chain vulnerabilities
- US EPA seeks data from PFAS makers
- European chemical makers call for more renewable energy
